ECTRIMS 2013: early effective treatment in MS

Highly-effective treatment works best the earlier you use it. #MSBlog #MSResearch

"As promised to several delegates the following is my presentation from the Biogen-Idec sponsored satellite symposium yesterday. Please note my disclosures. You need to know that I have been actively involved in the natalizumab development programme and therefore have conflicts of interest. The point I am trying to make in this presentation is that although highly-effective treatment works well it works even better the earlier you use it."

Labels: , ,